Skip to main content
Clinical Trials/NCT04801862
NCT04801862
Recruiting
Not Applicable

Clinical, Microbiological and Genetic Factors Associated With Recurrence of Clostridioides Difficile Infection and Development of a Predictive Tool for Recurrence

Hospital Universitario de Valme15 sites in 1 country750 target enrollmentJanuary 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Clostridium Difficile Infection
Sponsor
Hospital Universitario de Valme
Enrollment
750
Locations
15
Primary Endpoint
CDI recurrence
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Aim: To investigate if host factors, such as composition and diversity of intestinal microbiota and/or genetic determinants, are associated with a higher risk of recurrence of Clostridioides difficile infection (CDI). To generate a predictive tool based on epidemiological, clinical, genetic and microbiologic variables aimed to identify patients at a higher risk of CDI recurrence in a context of optimized ICD management. Design: Multicenter prospective cohort study. Patients: Older than 18 years patients with CDI diagnosis, made by IDSA criteria, in the participant centers.

Follow-up: A stewarship program aimed to improve CDI management, including early detection of CDI recurrence, will be implemented in the participant centers. Blood samples for genetic testing and stool samples for intestinal microbiome studies will be collected.

Variables and data analysis: The primary outcome variable will be the emergence of CDI recurrence. Potential independent predictors of recurrence, including genetic and microbiological factors, will be assessed. A predictive tool based on independent predictors of recurrence will be built in a development subpopulation. The performance of the model will be assessed by ROC curves, and sensititvity, especificity, as well as negative and positive predictive values will be calculated, both in the development subpopulation and in a validation subset.

Registry
clinicaltrials.gov
Start Date
January 1, 2021
End Date
December 31, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Hospital Universitario de Valme
Responsible Party
Principal Investigator
Principal Investigator

Nicolás Merchante

Coordinator of the UCEIM-HUV Research Group

Hospital Universitario de Valme

Eligibility Criteria

Inclusion Criteria

  • Age older than 18 years
  • New episode of Clostridioides difficile infection, based on IDSA criteria.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

CDI recurrence

Time Frame: First 8 weeks after end of therapy

Clostridioides difficile recurrence

CDI reinfection

Time Frame: Between 8 weeks after end of therapy and before 24 weeks

New episode of Clostridioides difficile infection

Secondary Outcomes

  • Readmission due to CDI infection(During 24 weeks after the end of therapy)

Study Sites (15)

Loading locations...

Similar Trials